1. Home
  2. ZNTL vs TTEC Comparison

ZNTL vs TTEC Comparison

Compare ZNTL & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • TTEC
  • Stock Information
  • Founded
  • ZNTL 2014
  • TTEC 1982
  • Country
  • ZNTL United States
  • TTEC United States
  • Employees
  • ZNTL N/A
  • TTEC N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • TTEC Retail: Computer Software & Peripheral Equipment
  • Sector
  • ZNTL Health Care
  • TTEC Technology
  • Exchange
  • ZNTL Nasdaq
  • TTEC Nasdaq
  • Market Cap
  • ZNTL 300.4M
  • TTEC 300.1M
  • IPO Year
  • ZNTL 2020
  • TTEC 1996
  • Fundamental
  • Price
  • ZNTL $4.01
  • TTEC $7.68
  • Analyst Decision
  • ZNTL Buy
  • TTEC Hold
  • Analyst Count
  • ZNTL 7
  • TTEC 4
  • Target Price
  • ZNTL $13.14
  • TTEC $9.67
  • AVG Volume (30 Days)
  • ZNTL 1.4M
  • TTEC 564.4K
  • Earning Date
  • ZNTL 08-07-2024
  • TTEC 08-01-2024
  • Dividend Yield
  • ZNTL N/A
  • TTEC 7.81%
  • EPS Growth
  • ZNTL N/A
  • TTEC N/A
  • EPS
  • ZNTL N/A
  • TTEC N/A
  • Revenue
  • ZNTL $40,560,000.00
  • TTEC $2,406,169,000.00
  • Revenue This Year
  • ZNTL N/A
  • TTEC N/A
  • Revenue Next Year
  • ZNTL N/A
  • TTEC $3.35
  • P/E Ratio
  • ZNTL N/A
  • TTEC N/A
  • Revenue Growth
  • ZNTL N/A
  • TTEC N/A
  • 52 Week Low
  • ZNTL $3.27
  • TTEC $5.01
  • 52 Week High
  • ZNTL $29.03
  • TTEC $34.52
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 34.80
  • TTEC 64.44
  • Support Level
  • ZNTL $3.83
  • TTEC $7.25
  • Resistance Level
  • ZNTL $4.79
  • TTEC $8.15
  • Average True Range (ATR)
  • ZNTL 0.45
  • TTEC 0.46
  • MACD
  • ZNTL 0.27
  • TTEC 0.23
  • Stochastic Oscillator
  • ZNTL 48.68
  • TTEC 83.74

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: